Commonwealth Equity Services
LTRN icon

Commonwealth Equity Services’s Lantern Pharma LTRN Stock Holding History

Commonwealth Equity Services’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,161
Closed -$79K – 4390
2025
Q3 		$79K Hold
18,161
– – ﹤0.01% 4119
2025
Q2 		$57K Buy
18,161
+5,464
+43% +$18.4K ﹤0.01% 4138
2025
Q1 		$45K Buy
+12,697
New +$52.7K ﹤0.01% 4077
2024
Q1 		– Sell
-58,848
Closed -$252K – 4062
2023
Q4 		$252K Buy
58,848
+43,480
+283% +$153K ﹤0.01% 3324
2023
Q3 		$52K Sell
15,368
-1,445
-9% -$6.56K ﹤0.01% 3656
2023
Q2 		$95K Sell
16,813
-3,373
-17% -$17.4K ﹤0.01% 3579
2023
Q1 		$97 Buy
+20,186
New +$106K ﹤0.01% 3500

Other funds holding LTRN

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Commonwealth Equity Services's LTRN Position: Q4 2025 in Review

Commonwealth Equity Services sold out of Lantern Pharma (LTRN) in Q4 2025, closing a stake of 18,161 shares — an estimated $79K sold.

Commonwealth Equity Services first reported a position in LTRN in Q1 2023 and held it in 7 quarters. The position peaked at $252K in Q4 2023. 33 funds tracked by Wall St. Rank hold LTRN as of Q4 2025.

  • Commonwealth Equity Services reported no remaining Lantern Pharma position as of Q4 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 18,161 Lantern Pharma shares in Q4 2025, an estimated $79K.
  • Commonwealth Equity Services first reported a position in Lantern Pharma in Q1 2023 and held it in 7 quarters.
  • Commonwealth Equity Services's Lantern Pharma position peaked at $252K in Q4 2023.
  • 33 funds tracked by Wall St. Rank held Lantern Pharma as of Q4 2025.

Based on Commonwealth Equity Services's 13F filing for Q4 2025, filed 12 Feb 2026.